{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:57:16Z","timestamp":1781704636589,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,20]],"date-time":"2026-12-20T00:00:00Z","timestamp":1797724800000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1040394"],"award-info":[{"award-number":["1040394"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI155908"],"award-info":[{"award-number":["R01AI155908"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114553","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:22:36Z","timestamp":1765930956000},"page":"114553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dose optimization of lymph node-targeted cyclosporine-A for lupus-driven vasculopathy"],"prefix":"10.1016","volume":"390","author":[{"given":"Kabirat T.","family":"Babalola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Ganugula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Mehrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.V. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114553_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.867155","article-title":"Coronary microvascular dysfunction in patients with systemic lupus erythematosus and chest pain","volume":"9","author":"Manchanda","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114553_bb0010","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/0961203309104865","article-title":"Colour doppler ultrasound of the ocular circulation in patients with systemic lupus erythematosus identifies altered microcirculatory haemodynamics","volume":"18","author":"Wright","year":"2009","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114553_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12440","article-title":"Microvascular involvement in systemic sclerosis and systemic lupus erythematosus","volume":"26","author":"Saygin","year":"2019","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jconrel.2013.04.027","article-title":"Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery","volume":"172","author":"Proulx","year":"2013","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2010-08-265892","article-title":"Cytokine release from innate immune cells: association with diverse membrane trafficking pathways","volume":"118","author":"Lacy","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1186\/s12967-024-05859-4","article-title":"The immune regulatory role of lymphangiogenesis in kidney disease","volume":"22","author":"Lu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114553_bb0035","first-page":"2954","article-title":"TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice","volume":"119","author":"Baluk","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114553_bb0040","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1038\/s41591-024-03233-x","article-title":"A foundation model for clinician-centered drug repurposing","volume":"30","author":"Huang","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114553_bb0045","series-title":"StatPearls","article-title":"Cyclosporine","author":"Tapia","year":"2024"},{"key":"10.1016\/j.jconrel.2025.114553_bb0050","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","article-title":"Modulation of innate immunity by cyclosporine A","volume":"163","author":"Liddicoat","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114553_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2019.109962","article-title":"Effects of cyclosporine on feline lymphocytes activated in vitro","volume":"219","author":"Cridge","year":"2020","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"6 Suppl 3","key":"10.1016\/j.jconrel.2025.114553_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0049-0172(92)90009-3","article-title":"Mechanisms of action of cyclosporine and effects on connective tissues","volume":"21","author":"Russell","year":"1992","journal-title":"Semin. Arthritis Rheum."},{"issue":"24","key":"10.1016\/j.jconrel.2025.114553_bb0065","doi-asserted-by":"crossref","first-page":"eabb3900","DOI":"10.1126\/sciadv.abb3900","article-title":"A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus","volume":"6","author":"Ganugula","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/pharmrev.123.000938","article-title":"Leveraging lymphatic system targeting in systemic lupus erythematosus for improved clinical outcomes","volume":"76","author":"Babalola","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114553_bb0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114553_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102359","article-title":"Lymph node targeting of cyclosporine ameliorates ocular manifestations in a mouse model of systemic lupus erythematosus (SLE) via PD-L1","volume":"57","author":"Ganugula","year":"2024","journal-title":"Nano Today"},{"issue":"21","key":"10.1016\/j.jconrel.2025.114553_bb0085","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/jacs.6b13231","article-title":"Next generation precision-polyesters enabling optimization of ligand-receptor stoichiometry for modular drug delivery","volume":"139","author":"Ganugula","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/pharmaceutics17020160","article-title":"Accelerated predictive stability testing: accelerating registration phase and application of reduced designs for shelf-life determination of parenteral drug product","volume":"17","author":"Pav\u010dnik","year":"2025","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114553_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114553_bb0100","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"1462","key":"10.1016\/j.jconrel.2025.114553_bb0105","first-page":"1935","article-title":"Defining operational taxonomic units using DNA barcode data","volume":"360","author":"Blaxter","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.jconrel.2025.114553_bb0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fphar.2014.00174","article-title":"Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research","volume":"5","author":"Tuntland","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1166\/jbn.2011.1278","article-title":"Nanoparticulate delivery can improve peroral bioavailability of cyclosporine and match Neoral Cmax sparing the kidney from damage","volume":"7","author":"Ankola","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2025.114553_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408440590917044","article-title":"Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications","volume":"35","author":"Calabrese","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114553_bb0125","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bone.2007.02.017","article-title":"Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation","volume":"40","author":"Yeo","year":"2007","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114553_bb0130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/ki.1994.466","article-title":"Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis","volume":"46","author":"Bergijk","year":"1994","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114553_bb0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-3083.1986.tb02128.x","article-title":"Effects of cyclosporin A on autoimmune disease in MRL\/1 and BXSB mice","volume":"24","author":"Berden","year":"1986","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0140","first-page":"234","article-title":"Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis","volume":"64","author":"Gunn","year":"1986","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114553_bb0145","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211110","article-title":"AP-1-independent NFAT signaling maintains follicular T cell function in infection and autoimmunity","volume":"220","author":"Seth","year":"2023","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0150","first-page":"377","article-title":"Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL\/Mp-lpr\/lpr mice","volume":"37","author":"Jabs","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41514-024-00155-3","article-title":"Current advances and future trends of hormesis in disease","volume":"10","author":"Wan","year":"2024","journal-title":"npj Aging"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114553_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158839","article-title":"Interleukin-6 induces vascular endothelial growth factor-C expression via Src-FAK-STAT3 signaling in lymphatic endothelial cells","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114553_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140853","article-title":"Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor\u2013mediated lymphangiogenesis","volume":"131","author":"Furlong-Silva","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells13010068","article-title":"Dysregulation of lymphatic endothelial VEGFR3 signaling in disease","volume":"13","author":"Kuonqui","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0175","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1038\/ncomms10824","article-title":"MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis","volume":"7","author":"Wong","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FTD.0000000000000589","article-title":"Biomarkers of drug-induced kidney toxicity","volume":"41","author":"Griffin","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114553_bb0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/14737159.2020.1768849","article-title":"Cystatin C as a biomarker of chronic kidney disease: latest developments","volume":"20","author":"Benoit","year":"2020","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114553_bb0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.1622","article-title":"Urinary clusterin, cystatin C, \u03b22-microglobulin and total protein as markers to detect drug-induced kidney injury","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114553_bb0195","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20154738","article-title":"Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis","volume":"49","author":"Wang","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jconrel.2025.114553_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799788","article-title":"Gut microbiota dysbiosis in systemic lupus erythematosus: novel insights into mechanisms and promising therapeutic strategies","volume":"12","author":"Pan","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114553_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal dysbiosis associated with systemic lupus erythematosus","volume":"5","author":"Hevia","year":"2014","journal-title":"mBio"},{"issue":"24","key":"10.1016\/j.jconrel.2025.114553_bb0210","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1128\/AEM.02676-14","article-title":"Dynamics of gut microbiota in autoimmune lupus","volume":"80","author":"Zhang","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114553_bb0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/microorganisms7080271","article-title":"The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors","volume":"7","author":"Lobionda","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2025.114553_bb0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.actbio.2021.01.016","article-title":"Polymeric materials for immune engineering: Molecular interaction to biomaterial design","volume":"133","author":"Soni","year":"2021","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114553_bb0225","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/vaccines11091395","article-title":"Polymer chemistry defines adjuvant properties and determines the immune response against the antigen or vaccine","volume":"11","author":"Shakya","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40168-017-0300-8","article-title":"Control of lupus nephritis by changes of gut microbiota","volume":"5","author":"Mu","year":"2017","journal-title":"Microbiome"},{"issue":"7682","key":"10.1016\/j.jconrel.2025.114553_bb0235","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates T(H)17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"issue":"6353","key":"10.1016\/j.jconrel.2025.114553_bb0240","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aah5825","article-title":"Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8\u03b1\u03b1(+) T cells","volume":"357","author":"Cervantes-Barragan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114553_bb0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-67577-0_9","article-title":"Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune suppression","volume":"1036","author":"Amobi","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"32","key":"10.1016\/j.jconrel.2025.114553_bb0250","doi-asserted-by":"crossref","first-page":"19376","DOI":"10.1073\/pnas.2000047117","article-title":"Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor","volume":"117","author":"Scott","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0255","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114553_bb0260","article-title":"Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels","volume":"24","author":"Ota","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114553_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29457","article-title":"Role of lymphatic endothelium specific hyaluronan receptor 1 in virus infection and associated diseases","volume":"96","author":"Dai","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2025.114553_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.610257","article-title":"Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus","volume":"7","author":"Amarnani","year":"2021","journal-title":"Front. Med."},{"issue":"22","key":"10.1016\/j.jconrel.2025.114553_bb0275","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.3390\/jcm11226714","article-title":"Systemic lupus erythematosus and lung involvement: a comprehensive review","volume":"11","author":"Shin","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114553_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101893","article-title":"Systemic lupus erythematosus and damage: What has changed over the past 20 years?","volume":"37","author":"Mu\u00f1oz-Grajales","year":"2023","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114553_bb0285","article-title":"Various ocular manifestations in systemic lupus erythematosus: a case series","volume":"16","author":"Sharum","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2025.114553_bb0290","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/OARRR.S384256","article-title":"Gastrointestinal manifestations in patients with systemic lupus erythematosus","volume":"14","author":"Alharbi","year":"2022","journal-title":"Open Access Rheumatol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114553_bb0295","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm1105","article-title":"Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung","volume":"10","author":"Lee","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114553_bb0300","first-page":"3261","article-title":"#3261 SAR131675, a selective Vegfr3 inhibitor, ameliorates renal inflammation and lymphangiogenesis in the murine lupus nephritis model","volume":"38","author":"Kang","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114553_bb0305","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/ATVBAHA.123.320326","article-title":"Profibrotic VEGFR3-dependent lymphatic vessel growth in autoimmune valvular carditis","volume":"44","author":"Osinski","year":"2024","journal-title":"ATVB"},{"issue":"21","key":"10.1016\/j.jconrel.2025.114553_bb0310","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.3390\/ijms222111628","article-title":"Corneal lymphangiogenesis: current pathophysiological understandings and its functional role in ocular surface disease","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114553_bb0315","doi-asserted-by":"crossref","first-page":"eaaw5075","DOI":"10.1126\/sciadv.aaw5075","article-title":"Lymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis","volume":"5","author":"Pei","year":"2019","journal-title":"Sci. Adv."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:22:22Z","timestamp":1781702542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":63,"alternative-id":["S0168365925011678"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114553","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose optimization of lymph node-targeted cyclosporine-A for lupus-driven vasculopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114553"}}